Analysis of IFT74as a candidate gene for chromosome 9p-linked ALS-FTD

Parastoo Momeni(National Institutes of Health), Jennifer C. Schymick(National Institute on Aging), Shushant Jain(National Institute on Aging), Mark Cookson(National Institute on Aging), Nigel J. Cairns(Washington University in St. Louis), Elisa Greggio(National Institute on Aging), Matthew Greenway(Royal College of Surgeons in Ireland), S Berger(National Institute on Aging), Stuart Pickering‐Brown(University of Manchester), Adriano Chiò, Hon‐Chung Fung(National Institute on Aging), David M. Holtzman(Washington University in St. Louis), Edward D. Huey(National Institute of Neurological Disorders and Stroke), Eric M. Wassermann(National Institute of Neurological Disorders and Stroke), Jennifer Adamson(Jacksonville College), Michael Hutton(Jacksonville College), Ekaterina Rogaeva(University of Toronto), Peter St George‐Hyslop(University of Toronto), Jeffrey D. Rothstein(Johns Hopkins University), Orla Hardiman(Beaumont Hospital), Jordan Grafman(National Institute of Neurological Disorders and Stroke), Andrew Singleton(National Institute on Aging), John Hardy(National Institute on Aging), Bryan J. Traynor(National Institute of Mental Health)
BMC Neurology
December 1, 2006
Cited by 71Open Access
Full Text

Abstract

BACKGROUND: A new locus for amyotrophic lateral sclerosis--frontotemporal dementia (ALS-FTD) has recently been ascribed to chromosome 9p. METHODS: We identified chromosome 9p segregating haplotypes within two families with ALS-FTD (F476 and F2) and undertook mutational screening of candidate genes within this locus. RESULTS: Candidate gene sequencing at this locus revealed the presence of a disease segregating stop mutation (Q342X) in the intraflagellar transport 74 (IFT74) gene in family 476 (F476), but no mutation was detected within IFT74 in family 2 (F2). While neither family was sufficiently informative to definitively implicate or exclude IFT74 mutations as a cause of chromosome 9-linked ALS-FTD, the nature of the mutation observed within F476 (predicted to truncate the protein by 258 amino acids) led us to sequence the open reading frame of this gene in a large number of ALS and FTD cases (n = 420). An additional sequence variant (G58D) was found in a case of sporadic semantic dementia. I55L sequence variants were found in three other unrelated affected individuals, but this was also found in a single individual among 800 Human Diversity Gene Panel samples. CONCLUSION: Confirmation of the pathogenicity of IFT74 sequence variants will require screening of other chromosome 9p-linked families.


Related Papers

No related papers found

Powered by citation graph analysis